全球眼部药物传输技术市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势与预测

全球眼部给药技术市场需求预计将从 2022 年的 182.1 亿美元增至 2030 年的近 428.5 亿美元，2023-2030 年研究期间复合CAGR为 11.29%。

眼部给药技术是指设计用于向眼睛给药的专门技术和系统。这些技术旨在有效地将治疗剂（例如药物或治疗方法）递送到特定的眼部组织和结构，以治疗各种眼部病症和疾病。

市场动态

由于多种驱动因素​​，眼部药物传输技术市场正在经历成长。首先，包括青光眼、黄斑部病变和糖尿病视网膜病变在内的眼部疾病的盛行率不断增加，刺激了对眼部治疗的先进药物传递系统的需求。技术创新发挥重要作用，奈米技术、植入物、缓释製剂和标靶递送系统的不断进步提高了眼部治疗的药物疗效和精确度。这些创新吸引投资并推动市场扩张。针对特定眼组织的标靶和受控药物传输需求也推动了市场成长，提供更有效的治疗选择，同时最大限度地减少全身副作用。此外，老年人口对眼部疾病的易感性导致对眼部药物输送系统的需求增加。不断增加的研发投资、患者对非侵入性治疗的偏好以及促进创新医疗技术的政府支持政策进一步刺激了市场。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球眼部药物传输技术市场的各个细分市场进行了包容性评估。眼部药物输送技术产业的成长和趋势为本研究提供了整体方法。

区域分析

本节涵盖区域展望，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲眼部给药技术市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。眼部药物传输技术市场的主要参与者包括Allergan Plc.、Bausch Health Company (Valeant Pharmaceuticals International).、Santen Pharmaceutical Co. Ltd.、Alimera Sciences Inc.、Ocular Therapeutix Inc.、Envisia Therapeutics Inc.、EyeGate Pharma Inc . .、诺华公司、强生视力保健公司和辉瑞公司。本部分包含竞争格局的整体视图，其中包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布和其他开发。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：眼部给药技术 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按技术分類的市场吸引力分析
  • 按疾病类型分類的市场吸引力分析
  • 最终用户的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球眼部药物传输技术市场分析：依技术分类

• 依技术概述
• 历史和预测数据
• 依技术分析
• 专题
• 离子电渗透疗法
• 眼插入物
• 眼内植入物
• 原位凝胶和泪点塞
• 其他的

第 6 章：全球眼部药物传输技术市场分析：依疾病类型

• 依疾病类型概述
• 历史和预测数据
• 依疾病类型分析
• 青光眼
• 糖尿病性视网膜病变
• 干眼症
• 黄斑部病变
• 白内障
• 糖尿病黄斑水肿
• 其他的

第 7 章：全球眼部药物传输技术市场分析：依最终使用者分类

• 最终用户概述
• 历史和预测数据
• 最终用户分析
• 医院
• 眼科诊所
• 门诊手术中心
• 家庭护理设置

第 8 章：全球眼部药物传输技术市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：眼部给药技术公司的竞争格局

• 眼部给药技术市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 公司股份分析
• 市场集中度
• Allergan Plc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Bausch Health Company (Valeant Pharmaceuticals International).
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Santen Pharmaceutical Co. Ltd.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Alimera Sciences Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Ocular Therapeutix Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Envisia Therapeutics Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• EyeGate Pharma Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Novartis AG.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Johnson & Johnson Vision Care Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Pfizer Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Ocular Drug Delivery Technology Market is presumed to reach the market size of nearly USD 42.85 BN by 2030 from USD 18.21 BN in 2022 with a CAGR of 11.29% under the study period 2023 - 2030.

Ocular drug delivery technology refers to specialized techniques and systems designed to administer medications to the eye. These technologies aim to effectively deliver therapeutic agents, such as drugs or treatments, to specific ocular tissues and structures for the treatment of various eye conditions and diseases.

MARKET DYNAMICS

The ocular drug delivery technology market is experiencing growth due to several driving factors. Primarily, the increasing prevalence of eye diseases, including glaucoma, macular degeneration, and diabetic retinopathy, fuels the demand for advanced drug delivery systems tailored for ocular treatments. Technological innovations play a significant role, with ongoing advancements in nanotechnology, implants, sustained-release formulations, and targeted delivery systems enhancing drug efficacy and precision in ocular treatments. These innovations attract investments and drive market expansion. The targeted and controlled drug delivery demand for specific eye tissues also propels market growth, offering more effective treatment options while minimizing systemic side effects. Additionally, the aging population's susceptibility to eye disorders contributes to increased demand for ocular drug delivery systems. Rising research and development investments, patient preference for non-invasive treatments, and supportive government policies promoting innovative healthcare technologies further stimulate the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ocular drug delivery technology. The growth and trends of ocular drug delivery technology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the ocular drug delivery technology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

• Topical
• Iontophoresis
• Ocular Insert
• Intraocular Implants
• In Situ Gel & Punctal Plugs
• Others

By Disease Type

• Glaucoma
• Diabetic Retinopathy
• Dry Eye Syndrome
• Macular Degeneration
• Cataract
• Diabetic Macular Edema
• Others

By End Users

• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers
• Homecare Settings

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Ocular Drug Delivery Technology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Ocular Drug Delivery Technology market include Allergan Plc., Bausch Health Company (Valeant Pharmaceuticals International)., Santen Pharmaceutical Co. Ltd., Alimera Sciences Inc., Ocular Therapeutix Inc., Envisia Therapeutics Inc., EyeGate Pharma Inc., Novartis AG., Johnson & Johnson Vision Care Inc., and Pfizer Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . OCULAR DRUG DELIVERY TECHNOLOGY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Technology
  • 3.7.2 Market Attractiveness Analysis By Disease Type
  • 3.7.3 Market Attractiveness Analysis By End Users
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY TECHNOLOGY

• 5.1 Overview by Technology
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Technology
• 5.4 Topical Historic and Forecast Sales by Regions
• 5.5 Iontophoresis Historic and Forecast Sales by Regions
• 5.6 Ocular Insert Historic and Forecast Sales by Regions
• 5.7 Intraocular Implants Historic and Forecast Sales by Regions
• 5.8 In Situ Gel & Punctal Plugs Historic and Forecast Sales by Regions
• 5.9 Others Historic and Forecast Sales by Regions

6 . GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY DISEASE TYPE

• 6.1 Overview by Disease Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Disease Type
• 6.4 Glaucoma Historic and Forecast Sales by Regions
• 6.5 Diabetic Retinopathy Historic and Forecast Sales by Regions
• 6.6 Dry Eye Syndrome Historic and Forecast Sales by Regions
• 6.7 Macular Degeneration Historic and Forecast Sales by Regions
• 6.8 Cataract Historic and Forecast Sales by Regions
• 6.9 Diabetic Macular Edema Historic and Forecast Sales by Regions
• 6.10. Others Historic and Forecast Sales by Regions

7 . GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY END USERS

• 7.1 Overview by End Users
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End Users
• 7.4 Hospitals Historic and Forecast Sales by Regions
• 7.5 Ophthalmic Clinics Historic and Forecast Sales by Regions
• 7.6 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
• 7.7 Homecare Settings Historic and Forecast Sales by Regions

8 . GLOBAL OCULAR DRUG DELIVERY TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE OCULAR DRUG DELIVERY TECHNOLOGY COMPANIES

• 9.1. Ocular Drug Delivery Technology Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF OCULAR DRUG DELIVERY TECHNOLOGY INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Allergan Plc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Bausch Health Company (Valeant Pharmaceuticals International).
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Santen Pharmaceutical Co. Ltd.
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Alimera Sciences Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Ocular Therapeutix Inc.
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Envisia Therapeutics Inc.
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. EyeGate Pharma Inc.
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Novartis AG.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Johnson & Johnson Vision Care Inc.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Pfizer Inc.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Technology (USD MN)
• Topical Market Sales by Geography (USD MN)
• Iontophoresis Market Sales by Geography (USD MN)
• Ocular Insert Market Sales by Geography (USD MN)
• Intraocular Implants Market Sales by Geography (USD MN)
• In Situ Gel & Punctal Plugs Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Disease Type (USD MN)
• Glaucoma Market Sales by Geography (USD MN)
• Diabetic Retinopathy Market Sales by Geography (USD MN)
• Dry Eye Syndrome Market Sales by Geography (USD MN)
• Macular Degeneration Market Sales by Geography (USD MN)
• Cataract Market Sales by Geography (USD MN)
• Diabetic Macular Edema Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End Users (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Ophthalmic Clinics Market Sales by Geography (USD MN)
• Ambulatory Surgical Centers Market Sales by Geography (USD MN)
• Homecare Settings Market Sales by Geography (USD MN)
• Global Ocular Drug Delivery Technology Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Ocular Drug Delivery Technology Report
• Market Research Process
• Market Research Methodology
• Global Ocular Drug Delivery Technology Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Technology
• Market Attractiveness Analysis by Disease Type
• Market Attractiveness Analysis by End Users
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Technology (USD MN)
• Topical Market Sales by Geography (USD MN)
• Iontophoresis Market Sales by Geography (USD MN)
• Ocular Insert Market Sales by Geography (USD MN)
• Intraocular Implants Market Sales by Geography (USD MN)
• In Situ Gel & Punctal Plugs Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Disease Type (USD MN)
• Glaucoma Market Sales by Geography (USD MN)
• Diabetic Retinopathy Market Sales by Geography (USD MN)
• Dry Eye Syndrome Market Sales by Geography (USD MN)
• Macular Degeneration Market Sales by Geography (USD MN)
• Cataract Market Sales by Geography (USD MN)
• Diabetic Macular Edema Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End Users (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Ophthalmic Clinics Market Sales by Geography (USD MN)
• Ambulatory Surgical Centers Market Sales by Geography (USD MN)
• Homecare Settings Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.